{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:49:47Z","timestamp":1789148987265,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10067-023-06506-x","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T01:07:29Z","timestamp":1673572049000},"page":"1469-1477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Refractory Takayasu arteritis with recurrent pyoderma gangrenosum: a therapeutic challenge with case-based review"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-1563","authenticated-orcid":false,"given":"Kaustav","family":"Bhowmick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6785-9985","authenticated-orcid":false,"given":"Rashmi","family":"Roongta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6475-1116","authenticated-orcid":false,"given":"Soumya","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2254-9075","authenticated-orcid":false,"given":"Sonali","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2451-8798","authenticated-orcid":false,"given":"Sumantro","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-444X","authenticated-orcid":false,"given":"Pradyot","family":"Sinhamahapatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9023-5169","authenticated-orcid":false,"given":"Parasar","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6654-9424","authenticated-orcid":false,"given":"Biswadip","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"6506_CR1","doi-asserted-by":"crossref","unstructured":"Zhang X, Jiao Y (2019) Takayasu arteritis with pyoderma gangrenosum: case reports and literature review. BMC Rheumatol\u00a03:45. https:\/\/doi.org\/10.1186%2Fs41927-019-0098-z","DOI":"10.1186\/s41927-019-0098-z"},{"issue":"8","key":"6506_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S2665-9913(20)30088-6","volume":"2","author":"N Acharya","year":"2020","unstructured":"Acharya N, Chattopadhyay A, Das A, Jain S (2020) Takayasu arteritis with pyoderma gangrenosum and superficial thrombophlebitis. The Lancet Rheumatol 2(8):5-e510. https:\/\/doi.org\/10.1016\/S2665-9913(20)30088-6","journal-title":"The Lancet Rheumatol"},{"key":"6506_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jdcr.2020.12.034","volume":"9","author":"DJ Choong","year":"2021","unstructured":"Choong DJ, Ng JL, Vinciullo C (2021) Pyoderma gangrenosum associated with Takayasu\u2019s arteritis in a young Caucasian woman and response to biologic therapy with tocilizumab. JAAD Case Rep 9:4\u20136. https:\/\/doi.org\/10.1016\/j.jdcr.2020.12.034","journal-title":"JAAD Case Rep"},{"issue":"8","key":"6506_CR4","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/art.41774","volume":"73","author":"M Maz","year":"2021","unstructured":"Maz M, Chung SA, Abril A, Langford CA, Gorelik M, Guyatt G et al (2021) American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol 73(8):1349\u20131365. https:\/\/doi.org\/10.1002\/art.41774","journal-title":"Arthritis Rheumatol"},{"key":"6506_CR5","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1111\/bcp.14756","volume":"87","author":"F Borgia","year":"2021","unstructured":"Borgia F, Sutera D, Spagnolo A, Mazza F, Bertino L, Cannav\u00f2 SP, Gallizzi R (2021) Onset of pyoderma gangrenosum after tocilizumab therapy for Takayasu arteritis: a new undescribed paradoxical reaction. Br J Clin Pharmacol 87:3378\u20133379. https:\/\/doi.org\/10.1111\/bcp.14756","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"6506_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41572-020-0213-x","volume":"6","author":"E Maverakis","year":"2020","unstructured":"Maverakis E, Marzano AV, Le ST, Callen JP, Br\u00fcggen MC, Guenova E, Dissemond J, Shinkai K, Langan SM (2020) Pyoderma gangrenosum Nat Rev Dis Primers 6(1):81. https:\/\/doi.org\/10.1038\/s41572-020-0213-x","journal-title":"Pyoderma gangrenosum Nat Rev Dis Primers"},{"issue":"3","key":"6506_CR7","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.26355\/eurrev_202102_24855","volume":"25","author":"AD Guarino","year":"2021","unstructured":"Guarino AD, Testa A, Mormile I, Imperatore N, Granata F, Rispo A, De Paulis A, Castiglione F (2021) Crohn\u2019s disease and Takayasu\u2019s arteritis: are they associated? Eur Rev Med Pharmacol Sci 25(3):1472\u20131484. https:\/\/doi.org\/10.26355\/eurrev_202102_24855","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"6506_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.31138\/mjr.31.2.174","volume":"31","author":"P Stamatis","year":"2020","unstructured":"Stamatis P (2020) Giant cell arteritis versus Takayasu arteritis: an update. Mediterr J Rheumatol. 31(2):174\u2013182. https:\/\/doi.org\/10.31138\/mjr.31.2.174","journal-title":"Mediterr J Rheumatol."},{"issue":"1","key":"6506_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","volume":"79","author":"B Hellmich","year":"2020","unstructured":"Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E et al (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79(1):19\u201330. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215672","journal-title":"Ann Rheum Dis"},{"key":"6506_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2017-211878","volume":"77","author":"Y Nakaoka","year":"2018","unstructured":"Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, Nomura A, Yoshida S, Nishimoto N (2018) Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77:348\u2013354. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211878","journal-title":"Ann Rheum Dis"},{"key":"6506_CR11","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/rheumatology\/kez630","volume":"59","author":"Y Nakaoka","year":"2020","unstructured":"Nakaoka Y, Isobe M, Tanaka Y, Ishii T, Ooka S, Niiro H et al (2020) Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study. Rheumatology (Oxford) 59:2427\u20132434. https:\/\/doi.org\/10.1093\/rheumatology\/kez630","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"6506_CR12","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1007\/s10067-021-05743-2","volume":"40","author":"DP Misra","year":"2021","unstructured":"Misra DP, Rathore U, Patro P, Agarwal V, Sharma A (2021) Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis\u2013a systematic review and meta-analysis. Clin Rheumatol 40(11):4391\u20134416. https:\/\/doi.org\/10.1007\/s10067-021-05743-2","journal-title":"Clin Rheumatol"},{"key":"6506_CR13","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/circulationaha.114.014321","volume":"132","author":"A Mekinian","year":"2015","unstructured":"Mekinian A, Comarmond C, Resche-Rigon M, Mirault T, Kahn JE, Lambert M et al (2015) Efficacy of biological-targeted treatments in Takayasu arteritis multicenter, retrospective study of 49 patients. Circulation 132:1693\u20131700. https:\/\/doi.org\/10.1161\/circulationaha.114.014321","journal-title":"Circulation"},{"key":"6506_CR14","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/art.40037","volume":"69","author":"CA Langford","year":"2017","unstructured":"Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S et al (2017) A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheum 69:846\u2013853. https:\/\/doi.org\/10.1002\/art.40037","journal-title":"Arthritis Rheum"},{"key":"6506_CR15","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/rheumatology\/kex493","volume":"57","author":"D Nakagomi","year":"2018","unstructured":"Nakagomi D, Kronbichler A, Witte T, Mohammad AJ, Jayne DRW (2018) Comment on: Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature. Rheumatology (Oxford) 57:1309\u20131310. https:\/\/doi.org\/10.1093\/rheumatology\/kex493","journal-title":"Rheumatology (Oxford)"},{"key":"6506_CR16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/rheumatology\/kex249","volume":"57","author":"G Pazzola","year":"2018","unstructured":"Pazzola G, Muratore F, Pipitone N, Crescentini F, Cacoub P, Boiardi L et al (2018) Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature. Rheumatology (Oxford) 57:1151\u20131155. https:\/\/doi.org\/10.1093\/rheumatology\/kex249","journal-title":"Rheumatology (Oxford)"},{"key":"6506_CR17","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1093\/rheumatology\/keaa281","volume":"59","author":"J Li","year":"2020","unstructured":"Li J, Li M, Tian X, Zeng X (2020) Tofacitinib in patients with refractory Takayasu\u2019s arteritis. Rheumatology (Oxford) 59:e95\u2013e98. https:\/\/doi.org\/10.1093\/rheumatology\/keaa281","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6506_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/annrheumdis-2021-220832","volume":"81","author":"X Kong","year":"2022","unstructured":"Kong X, Sun Y, Dai X, Wang L, Ji Z, Chen H, Jin X, Ma L, Jiang L (2022) Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study. Ann Rheum Dis 81(1):117\u2013123. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220832","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"6506_CR19","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/ced.14683","volume":"46","author":"VE Orfaly","year":"2021","unstructured":"Orfaly VE, Kovalenko I, Tolkachjov SN, Ortega-Loayza AG, Nunley JR (2021) Tofacitinib for the treatment of refractory pyoderma gangrenosum. Clin Exp Dermatol 46(6):1082\u20131085. https:\/\/doi.org\/10.1111\/ced.14683","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"6506_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T (2020) Translating IL-6 biology into effective treatments. Nat Rev Rheumatol 16(6):335\u2013345. https:\/\/doi.org\/10.1038\/s41584-020-0419-z","journal-title":"Nat Rev Rheumatol"},{"key":"6506_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2230.2004.01514.x","volume":"29","author":"H Ujiie","year":"2004","unstructured":"Ujiie H, Sawamura D, Yokota K, Nishie W, Shichinohe R, Shimizu H (2004) Pyoderma gangrenosum associated with Takayasu\u2019s arteritis. Clin Exp Dermatol 29:357\u2013359. https:\/\/doi.org\/10.1111\/j.1365-2230.2004.01514.x","journal-title":"Clin Exp Dermatol"},{"key":"6506_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1365-2230.2009.03534.x","volume":"35","author":"A Minagawa","year":"2010","unstructured":"Minagawa A, Uhara H, Saida T (2010) Takayasu\u2019s arteritis with pyoderma gangrenosum and necrotizing vasculitis. Clin Exp Dermatol 35:329\u2013330","journal-title":"Clin Exp Dermatol"},{"key":"6506_CR23","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jaad.2008.05.010","volume":"59","author":"S Ghosn","year":"2008","unstructured":"Ghosn S, Malek J, Shbaklo Z, Matta M, Uthman I (2008) Takayasu disease presenting as malignant pyoderma gangrenosum in a child with relapsing polychondritis. J Am Acad Dermatol 59:S84\u2013S87. https:\/\/doi.org\/10.1016\/j.jaad.2008.05.010","journal-title":"J Am Acad Dermatol"},{"key":"6506_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1365-2133.1999.02989.x","volume":"141","author":"LA Fearfield","year":"1999","unstructured":"Fearfield LA, Ross JR, Farrell AM, Costelle C, Bunker CB, Staughton RC (1999) Pyoderma gangrenosum associated with Takayasu\u2019s arteritis responding to cyclosporine. Br J Dermatol 141:339\u2013343. https:\/\/doi.org\/10.1046\/j.1365-2133.1999.02989.x","journal-title":"Br J Dermatol"},{"key":"6506_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1525-1470.1995.tb00122.x","volume":"12","author":"O Dagan","year":"1995","unstructured":"Dagan O, Barak Y, Metzker A (1995) Pyoderma gangrenosum and sterile multifocal osteomyelitis preceding the appearance of Takayasu arteritis. Pediatr Dermatol 12:39\u201342. https:\/\/doi.org\/10.1111\/j.1525-1470.1995.tb00122.x","journal-title":"Pediatr Dermatol"},{"key":"6506_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3899\/jrheum.160491","volume":"44","author":"G Vettiyil","year":"2017","unstructured":"Vettiyil G, Punnen A, Kumar S (2017) An unusual association of chronic recurrent multifocal osteomyelitis, pyoderma gangrenosum and Takayasu arteritis. J Rheumatol 44:127\u2013128. https:\/\/doi.org\/10.3899\/jrheum.160491","journal-title":"J Rheumatol"},{"key":"6506_CR27","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3109\/14397595.2013.844384","volume":"25","author":"A Barrera-Vargas","year":"2015","unstructured":"Barrera-Vargas A, Granados J, Garcia-Hidalgo L, Hinojosa-Azaola A (2015) An unusual presentation of Takayasu\u2019s arteritis in two Mexican siblings. Mod Rheumatol 25:802\u2013805. https:\/\/doi.org\/10.3109\/14397595.2013.844384","journal-title":"Mod Rheumatol"},{"key":"6506_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jdcr.2016.12.006","volume":"3","author":"K Okamura","year":"2017","unstructured":"Okamura K, Konno T, Onami K, Nikaido M, Okazaki N, Abe Y, Hayashi M, Yaguchi Y, Sato H, Konta T, Suzuki T (2017) A case of primarily facial pyoderma gangrenosum associated with Takayasu arteritis. JAAD Case Rep 3:124\u2013126. https:\/\/doi.org\/10.1016\/j.jdcr.2016.12.006","journal-title":"JAAD Case Rep"},{"key":"6506_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000452829","volume":"8","author":"J Loetscher","year":"2016","unstructured":"Loetscher J, Fistarol S, Walker UA (2016) Pyoderma gangrenosum and erythema nodosum revealing Takayasu\u2019s arteritis. Case Rep Dermatol 8:354\u20137. https:\/\/doi.org\/10.1159\/000452829","journal-title":"Case Rep Dermatol"},{"key":"6506_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1684\/ejd.2009.0635","volume":"19","author":"K Futaki","year":"2009","unstructured":"Futaki K, Komine M, Hosoda S, Hirashima M, Yokokura H, Yamada T, Murata S, Matsuyama Y, Nagashima T, Nara H, Minota S, Ohtsuki M (2009) Pyoderma gangrenosum associated with Takayasu\u2019s arteritis without typical symptoms. Eur J Dermatol 19:266\u2013267","journal-title":"Eur J Dermatol"},{"key":"6506_CR31","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S0151-9638(07)91510-0","volume":"134","author":"A Aoussar","year":"2007","unstructured":"Aoussar A, Ismaili N, Berbich L, Tazi Mezalek Z, Alt Ourhrouil M, Senouci K, Mansouri F, Hassam B (2007) Pyoderma gangrenosum revealing Takayasu\u2019s arteritis. Ann Dermatol Venereol 134:264\u2013267","journal-title":"Ann Dermatol Venereol"},{"key":"6506_CR32","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.athoracsur.2004.06.098","volume":"80","author":"S Kanemistu","year":"2005","unstructured":"Kanemistu S, Shimono T, Kusagawa H, Onoda K, Yada I (2005) Successful surgical treatment of Takayasu\u2019s arteritis associated with pyoderma gangrenosum. Ann Thorac Surg 80:1914\u20131916. https:\/\/doi.org\/10.1016\/j.athoracsur.2004.06.098","journal-title":"Ann Thorac Surg"},{"key":"6506_CR33","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1001\/archderm.1991.01680100135027","volume":"127","author":"SH Fullerton","year":"1991","unstructured":"Fullerton SH, Abel EA, Getz K, el Ramahi K (1991) Cyclosporine treatment of severe recalcitrant pyoderma gangrenosum in a patient with Takayasu\u2019s arteritis. Arch Dermatol 127:1731\u20132. https:\/\/doi.org\/10.1001\/archderm.1991.01680100135027","journal-title":"Arch Dermatol"},{"key":"6506_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000247820","volume":"181","author":"C Frances","year":"1990","unstructured":"Frances C, Boisnic S, Bletry O, Dallot A, Thomas D, Kieffer E, Godeau P (1990) Cutaneous manifestations of Takayasu arteritis: a retrospective study of 80 cases. Dermatologica 181:266\u2013272. https:\/\/doi.org\/10.1159\/000247820","journal-title":"Dermatologica"},{"key":"6506_CR35","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/s0190-9622(87)70289-8","volume":"17","author":"CV Perniciaro","year":"1987","unstructured":"Perniciaro CV, Winkelmann RK, Hunder GG (1987) Cutaneous manifestations of Takayasu\u2019s arteritis: a clinicopathologic correlation. J Am Acad Dermatol 17:998\u20131005. https:\/\/doi.org\/10.1016\/s0190-9622(87)70289-8","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06506-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06506-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06506-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T06:17:56Z","timestamp":1681366676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06506-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["6506"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06506-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Written consent has been obtained from the patient for the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}